Initial, presumptive therapy for serious acute gram-negative rod infections: preliminary report of a controlled clinical trial.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002509:Cephaloridine / Q000627:therapeutic use; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011113:Polymyxins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011113:Polymyxins; D007612:Kanamycin; D002509:Cephaloridine